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Heart and skeletal muscle inflammation (HSMI) and cardiomyopathy syndrome (CMS) are putative viral cardiac diseases of
Atlantic salmon. This study examined the levels and correlated the serum enzymes creatine kinase (CK) and lactate dehydrogenase
(LDH) to the histopathology of clinical outbreaks of HSMI and chronic CMS in farmed Atlantic salmon. A total of 75 fish from
3 diﬀerent HSMI outbreaks, 30 chronic CMS fish, and 68 fish from 3 nondiseased fish groups were used as the study population
(N = 173). Serum CK and LDH levels correlated significantly with the total inflammation and total necrosis scores for HSMI
fish (P = 0.001). However, no correlation was identified for enzyme levels and histopathology scores for chronic CMS fish. The
significantly increased CK and LDH levels and their positive correlations to histopathology diﬀerentiate HSMI fromCMS clinically
suggesting the potential use of enzymes for screening for HSMI is promising.
1. Introduction
The marine farmed Atlantic salmon (Salmo salar L.) exhibits
a variety of cardiac diseases, and the reason for this likely
includes low activity in relatively confined spaces, continuous
food supply, low oxygen level, crowding, stress in handling,
and temperature [1]. The cardiac anomalies and defects of
Atlantic salmon include aplasia or hypoplasia of the septum
transversum, abnormal location and shape of heart [1],
arteriosclerosis [2, 3], and ventricular hypoplasia [4], but
specific diseases include cardiomyopathy syndrome (CMS)
[5–7], pancreas disease (PD) [8–10], and heart and skeletal
muscle inflammation (HSMI) [11, 12]. Annual economical
losses due to cardiomyopathy syndrome (CMS) alone have
been estimated up to C 4.5–8.8 millions [7].
Heart and skeletal muscle inflammation (HSMI) is a
disease of marine farmed Atlantic salmon reported from
Norway, Scotland and Chile. HSMI is a disease which mainly
aﬀects heart and red skeletal muscle. It is typically a disease
of moderate mortality (∼20%) but high morbidity (∼100%)
that aﬀects fish 5 to 9 months after transfer to sea. Presently,
HSMI can be diagnosed by histopathology and presents
as epi- and endocarditis as well as mononuclear cellular
infiltration of both trabecular and compact layers of ventricle
myocardium accompanied by myocytic necrosis [11–14].
HSMI is transmissible in laboratory studies by injecting
tissue homogenate from diseased fish to healthy fish [11, 15],
and recently piscine reovirus (PRV) has been suggested to
be associated with HSMI infection [16, 17]. Lesions first
appear and are more frequent in heart than red skeletal
muscle. Aﬀected myocytes show signs of degeneration, loss
of cardiomyocytes striation and eosinophilia, loss of skeletal
muscle striation, vacuolation, centralized nuclei, and karyor-
rhexis. There are more inflammatory changes as compared to
necrotic changes in heart and red skeletal muscle [1, 12, 13].
HSMI has become more significant where outbreaks have
increased from 54 in 2004 [18] to 162 cases reported in 2011
[19].
Cardiomyopathy syndrome (CMS) is a cardiac disease of
Atlantic salmon with a suggested totiviral etiology [20] that
mainly aﬀects atrium and trabecular ventricle myocardium
without involvement of skeletal muscle. It shares similar
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features with HSMI where both cause myocarditis [1]. His-
topathological changes include necrosis and inflammation of
trabecular layer of ventricle and atrium, epicarditis, cellular
infiltrates of mainly mononuclear lymphocytes and macro-
phages, and rupture of atrium or sinus venosus macro-
scopically [1, 5]. CMS aﬀects adult salmon after 12–18
months of sea transfer, and recently a totivirus (piscine
myocarditis virus (PMCV)) is proposed as causative agent
for cardiomyopathy [5, 17, 20, 21]. The piscine myocarditis
virus is a double-stranded RNA virus with diameter of
50 nm and 6688 bp genome size [21]. The haematological
tests and serum analysis for fish, compared with other areas
of veterinary medicine, are not common place compared
to higher vertebrates due to the lack of reference values
for clinical chemistry (physiological and pathological) and
understanding of disease pathogenesis and pathophysiology
[22–24]. There is a strong need for blood biochemistry
ranges especially where the etiology is unclear (HSMI and
CMS) since the associated viruses can be present asymp-
tomatically [17, 25]. Biochemical enzymes such as creatine
kinase (CK) and lactate dehydrogenase (LDH) are well-
established biomarkers of cardiac disease in humans [26]
and are often used in conjunction with other hormonal
biomarkers for a myocardial dysfunction diagnosis [27].
Both enzymes are released upon cellular degeneration such
as necrosis. Lactate dehydrogenase (LDH) is involved in the
interconversion of pyruvate and L lactate during the final
reactions of glycolysis and is present in the cytoplasm of all
cells (nucleated and nonnucleated cells). In humans, raised
LDH plasma values are observed from 8 to 12 h, peaking
within 2–3 days, and levels are sustained for duration of 7–10
days following cardiac injury [28]. Creatine kinase (CK), on
the other hand, is found in themyocyte cytoplasm, sarcoplas-
mic reticulum, mitochondria, and myofibrils with a half-life
of about 12 h in humans. Creatine kinase levels in blood
plasma rise from 4 to 6 h peaking at 12–36 h and sustained
over 3-4 days in humans where a cardiac injury has occurred
[28]. The creatine kinase concentrations are related to the
irreversible injury associated with myocardial necrosis in
mammals (dogs) [29]. The elevated CK levels have been re-
ported in association with myocytic necrosis seen in pancre-
as disease (PD) in Atlantic salmon [30, 31], and these results
suggested that CK could be a useful candidate indicator of
cardiac diseases in Atlantic salmon.
The aims of the present study were to measure the serum
CK and LDH levels and examining their relationship to the
cardiac diseases (HSMI and CMS) of Atlantic salmon.
2. Material and Methods
2.1. Fish Sampling. Seven groups of Atlantic salmon (Salmo
salar L.) were involved in this study. All samples from
diseased fish were taken from the farms diagnosed with
both diseases by National Veterinary Institute, Oslo, Norway
(NVI) and further histopathology was performed to confirm
the disease diagnosis during the study. Group 1 (n = 28)
consisted of fish (S1) collected from a confirmed HSMI
outbreak at a sea site during the peak mortality of the HSMI
episode. Group 2 (n = 16) comprised fish (S0) collected from
a confirmed HSMI sea cage outbreak two months after peak
mortality period. Group 3 (n = 31) included fish (S0) from
a sea cage site collected during the early onset of a HSMI
outbreak. The clinical phase of the disease has been defined
as the time period with increased mortality at farm due to
HSMI [32]. The disease phase was determined from the peak
mortality time at the farm [16]. All diseased groups were
in the sea phase of salmon production and opportunistic
samples collected from diseased cages on each farm. All
three diseased farms were widely distant from each other
in Nordland county, Norway. Group 4 (n = 30) included
chronic CMS infected fish (S2) and had confirmed CMS
outbreak in the past, and sampling was performed 6 months
after CMS outbreak. Diseased groups included fish with
average weight range (600–1000 g) for HSMI and (6000–
7000 g) for CMS fish.
Group 5 (n = 28) was nondiseased fish which were taken
from a study where Atlantic salmon (S0) had been made
anaemic using phenylhydrazine, and cardiac hypertrophy
had been characterized [33]. Group 6 (n = 20) consisted
of nondiseased, apparently healthy fish (S0 + S1) kept in a
laboratory facility (University of Nordland, Mørkvedbukta
Research Station, Bodo, Norway) in 2m3 tanks with fresh
ambient sea water (temperature range 7-8◦C) and fed 0.7%
commercial feed (Spirit, Skretting, Stavanger, Norway) of
their body weight three times weekly. Group 7 (n = 20) com-
prised of apparently healthy, nondiseased Atlantic salmon
(S1) from the sea cages. Nondiseased groups included fish
with average weight range (400–2000 g).
2.2. Blood Collection. All fish were killed by a blow to the
head or overdose of tricaine methanesulfonate (MS222)
(100mgmL−1). Blood was collected immediately from the
caudal vein with a 5mL syringe using 23 G needle, allowed
to clot in Eppendorf tubes for 2–4 h, centrifuged at 8,000 g
for 5min, and the serum collected except group 4 where
heparinised blood plasma was collected and frozen at−20◦C.
2.3. Serum Analysis. All samples were frozen and sent on dry
ice to Norwegian School of Veterinary Sciences, Oslo Central
Laboratory and to the Nordland Hospital, Department of
Medicine Biochemistry, Bodo for creatine kinase (CK) and
lactate dehydrogenase (LDH) analysis. Creatine kinase (CK)
and lactate dehydrogenase (LDH) were measured by using
ADIVA 1650 (Siemens Medical Solution Diagnostics Inc.,
Tarrytown, NY, USA) at Norwegian school of veterinary
sciences, Oslo central laboratory and ADVIA 1650/1800
(Bayer Diagnostics, Tarrytown, NY, USA) at Nordland
Hospital, Department of Medicine Biochemistry, Bodo on
the basis of their enzyme activity and measured by increase
in absorbance at 340/410 nm. Both laboratories used the
same methods. Briefly the principle of the procedures for
LDH and CK is as follows: LD catalyzes the conversion
of L lactate to pyruvate in the presence of nicotinamide
adenine dinucleotide (NAD). The enzyme activity of LD is
proportional to the rate of production of NADH (reduced
NAD). Creatine kinase reacts with creatine phosphate and
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ADP to form ATP which is coupled to the hexokinase-G6PD
reaction, generating NADPH. The concentrations of NADH
and NADPH were measured by the increase in absorbance at
340/410 nm for LDH and CK, respectively.
2.4. Histopathology and Scoring Method. To correlate bio-
chemical enzymes (CK and LDH), histopathology was
method of choice for diagnosis of HSMI. Hearts, skeletal
red and white muscle from below the dorsal fin and above
the lateral line, and other vital organs, were collected and
fixed in 10% neutral phosphate-buﬀered formalin solution.
External and internal visual examination was performed in
addition to histological observation of other vital organs
for other abnormalities or signs of overt disease in the fish.
Tissues were processed by a standard paraﬃn wax protocol
(dehydrated, embedded in paraﬃn, 3 µm thick sectioned
and H and E stained) and examined for changes (necrosis
and inflammation) characteristic of HSMI [11]. The case
definition for HSMI includes inflammation and necrosis of
trabecular and compact ventricle myocardium, epicarditis,
endocarditis, mononuclear inflammatory cell infiltration,
and a higher level of inflammation compared with necrosis
while supportive signs may also include inflammation and
necrosis of red skeletal muscle, atrium, and absence of
pancreatic lesions [32]. A semiquantitative assessment of
each slide was adapted from McLoughlin et al. [34] for
scoring histopathological findings in heart andmuscle tissues
obtained from seven groups of fishes used in this study. It has
been used and established in PD, a similar cardiac disease to
HSMI and CMS (Table 1).
2.5. Diﬀerent Anatomical Regions. The scoring method was
used for the detailed study of the tissue in anatomically
distinct areas of the heart and skeletal muscle: (1) atrial
trabecular myocardial inflammation, (2) and necrosis, (3)
atrial epicarditis, (4) ventricle compact myocardial inflam-
mation, (5) and necrosis, (6) ventricle trabecular myocardial
inflammation, (7) and necrosis, (8) ventricle epicarditis,
(9) skeletal muscle inflammation, (10) and necrosis. A
total inflammation score was determined from the summed
scores of all parameters (atrial and ventricular trabecular
inflammation, atrial and ventricular epicarditis, ventricle
compact inflammation, and skeletal muscle inflammation)
and total necrosis score determined from the summed scores
of all parameters (atrial and ventricular trabecular necrosis,
ventricle compact necrosis, and skeletal muscle necrosis).
The sum scores of inflammation and necrosis in heart
and skeletal muscle were correlated with the biochemical
enzymes (CK and LDH) levels. Total inflammation and total
necrosis scores were correlated to the HSMI plus nondiseased
fish and the CMS fish plus nondiseased fish to diﬀerentiate
the enzymatic eﬀects in each disease separately.
2.6. Slides Evaluation. Slides were evaluated blindly by two
persons, histopathological results compared between the
groups and correlated with respective biochemical enzymes
values for each sample. Sometimes the conflict for slide score
was around 0.5–1 between two persons, and then they agreed
Table 1: Semiquantitative lesion scoring system adapted from
McLoughlin et al. [34]. System covers heart and skeletal muscle
lesions separately. Lesions starting from 0 (healthy tissue) to 3
(severe changes). (a) Heart lesion classification. (b) Skeletal muscle
classification.
Score Description
(a)
0 Normal appearance
1 Focal myocytic necrosis ± inflammation (<50 fibers aﬀected)
2
Multifocal myocytic necrosis ± inflammation (50–100 fibers
aﬀected)
3
Severe diﬀuse myocytic necrosis ± inflammation (>100
fibers aﬀected)
(b)
0 Normal appearance
1 Focal myocytic necrosis ± inflammation
2 Multifocal myocytic necrosis ± inflammation
3 Severe diﬀuse myocytic necrosis ± inflammation
after discussing case definition and scoring system on most
suitable score for the slide.
2.7. Statistical Analysis. Spearman rank coeﬃcient corre-
lations were performed using SigmaPlot (10.0) and were
considered statistically significant at P values ≤0.05. The
mean histopathology (total inflammation and total necrosis
scores) and enzyme (CK and LDH) values were analyzed
using Kruskal-Wallis One Way Analysis of Variance on ranks
with diﬀerences isolated using Dunn’s post hoc analysis. Data
were presented as mean ± SD.
3. Results
The highest and lowest mean CK values were identified in
HSMI fish group 1 = 16479.25±1844.49 IU.L−1 and nondis-
eased fish group 5 = 1581.71 ± 425.33 IU.L−1 respectively.
However, the highest and lowest mean LDH values were
identified in HSMI fish group 2 = 1838.25 ± 957.47 IU.L−1
and nondiseased fish group 5 = 235.39 ± 27.43 IU.L−1,
respectively. The mean CK and LDH values for CMS fish
were (5207.93 ± 967.81 IU.L−1) and (426.2 ± 60.68 IU.L−1),
respectively (Table 4).
Diseased group 1 (HSMI fish) had significantly the
highest levels for CK activity as compared to other HSMI
groups 2 and 3 (Kruskal-Wallis One-Way Analysis: H =
65.217, d.f. = 6; (P ≤ 0.001) (Figure 2(a)). However,
LDH activity levels were higher in HSMI fish (group 3) as
compared to other HSMI fish (groups 1 and 2) (Kruskal-
Wallis One-Way Analysis: H = 73.838, d.f. = 6; P ≤ 0.001)
(Figure 2(b)). The CMS (group 4) CK and LDH values were
significantly diﬀerent from nondiseased fish (groups 5, 6,
and 7) (Figures 2(a) and 2(b)).
The scoring grades which were used to score the inflam-
matory changes represented by micrographs (Figure 1) and
reflected the semiquantitative scoring system which was
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Grade 0
50 µm
(a)
Grade 1
50 µm
(b)
Grade 2
50 µm
(c)
Grade 3
50 µm
(d)
Figure 1: The representative micrographs of the semiquantitative scoring system described in Table 1, represented the heart histopathology.
Grade 0: no pathological changes. Grade 1: minor inflammatory lesions comprises of focal subendocardial mononuclear leukocytes. Grade
2: several distinct lesions with moderately increased number of mononuclear leukocytes. Grade 3: severe lesions where almost all myofibres
have been replaced by inflammatory cells, predominantly by mononuclear lymphocyte-like cells. Arrow: inflammation. Scale bars = 50 µm.
Table 2: Total mean (± SD) scores of inflammation and necrosis for HSMI (groups 1, 2, and 3), CMS (group 4), and nondiseased fish
(groups 5, 6, and 7) in heart and heart with skeletal muscle. Diﬀerent letters represent significant diﬀerences between groups (P < 0.05).
Parameter Nondiseased HSMI CMS
Inflammation
Heart 0.83± 0.30 5.30± 1.16 2.44± 1.39
Heart + muscle 0.99± 0.16a 5.59± 1.03b 2.44± 1.39c
Necrosis
Heart 0.35± 0.36 2.01± 1.34 0.1± 0.40
Heart + muscle 0.62± 0.45a,c 2.92± 1.15b 0.38± 0.68c
applied to each anatomical region of the heart (atrium, com-
pact and trabecular ventricular myocardium, pericardium)
and the red skeletal muscle (Table 1).
Seven fish groups were compared on the basis of inflam-
mation and necrosis scores. Inflammatory mononuclear
cells were more frequent as compared to focal areas of
necrosis in heart tissue, but the opposite was apparent
in the red skeletal muscle where necrosis predominated.
The mean total inflammation (Kruskal-Wallis One-Way
Analysis: H = 111.216, d.f. = 2; (P ≤ 0.001) and total necrosis
(Kruskal-Wallis One-Way Analysis: H = 90.484, d.f. = 2; (P ≤
0.001) scores of HSMI and CMS fish were significantly diﬀer-
ent from nondiseased fish with the exception of total necrosis
scores of CMS fish which were not significantly diﬀerent
from nondiseased fish (Table 2). More lesions were present
in the heart as compared to the skeletal muscle (Table 2).
Total inflammation scores ranged from 1 to 11 in diseased
groups while 0 to 3.5 in nondiseased groups. Total necrosis
scores ranged from 0 to 7 for diseased groups while from
0 to 3 for nondiseased groups. Total necrosis (Kruskal-
Wallis One-Way Analysis: H = 118.135, d.f. = 6; (P ≤
0.001) (Figure 3(b)) and total inflammation (Kruskal-Wallis
One-Way Analysis: H = 119.558, d.f. = 6; (P ≤ 0.001)
(Figure 3(a)) scores were compared for all seven groups
and identified higher scores in HSMI group 1 while being
significant and lower in the group 2 and 3 as compared
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Figure 2: The box plots of (a) creatine kinase (CK) and (b) lactate dehydrogenase (LDH) enzymes activity values in the serum/plasma of
Atlantic salmon for all seven groups (N = 173). Group 1 (n = 28) and group 2 (n = 16) represented fish from an acute and late phase of a
HSMI outbreak, respectively, while group 3 (n = 31) represented values from fish from an early phase of HSMI. Group 4 (n = 30) included
chronic CMS fish. Group 5 (n = 28), group 6 (n = 20), and group 7 (n = 20) represented values from nondiseased fish. Bars with diﬀerent
letters represented significant diﬀerences between groups (P < 0.05). (◦) denotes outliers.
to none to low level of changes seen in nondiseased fish
(groups 5, 6, and 7) (Figures 3(a) and 3(b)). In general,
muscle necrosis and inflammation (cardiac and skeletal)
were negligible to mild in nondiseased fish (groups 5, 6,
and 7) as compared to CMS and HSMI fish (groups 1, 2, 3,
and 4). Total inflammation and total necrosis results of all
HSMI-diseased fish (groups 1, 2, and 3) were significantly
diﬀerent from nondiseased groups (groups 5, 6, and 7) with
the exceptions of total necrosis scores of CMS fish (group 4)
which was not significantly diﬀerent from nondiseased fish
(group 6) (Figures 3(a) and 3(b)).
The histopathology scores (sum score of heart and
muscle necrosis and inflammation) were correlated with
serum/plasma CK and LDH levels. The correlations which
were made among CK enzyme levels, and diﬀerent anatom-
ical parameters of all fish groups excluding CMS fish (group
4) gave significant relationships (P ≤ 0.001) (Table 3). The
significant correlations of CK levels to individual parameters
included atrial inflammation (S coeﬀ. = 0.451, P < 0.001),
atrial necrosis (S coeﬀ. = 0.252, P = 0.002), atrial epicarditis
(S coeﬀ. = 0.314, P < 0.001), ventricle compact layer
inflammation (S coeﬀ. = 0.440, P < 0.001), ventricle compact
layer necrosis (S coeﬀ. = 0.249, P = 0.002), ventricle trabec-
ular inflammation (S coeﬀ. = 0.526, P < 0.001), ventricle
trabecular necrosis (S coeﬀ. = 0.283, P < 0.001), ventricle
epicarditis (S coeﬀ. = 0.333, P < 0.001), skeletal muscle
necrosis (S coeﬀ. = 0.206, P = 0.035), and skeletal muscle
inflammation (S coeﬀ. = 0.169, P = 0.084). The CK enzyme
levels significantly and positively correlated with the both
total inflammation (S coeﬀ. = 0.552, P < 0.001) and total
necrosis (S coeﬀ. = 0.526, P < 0.001) scores (Table 3). The
LDH levels were also correlated in the same manner as above
for CK which showed significant relationships (P = 0.05)
(Table 3). The significant correlations for LDH levels to dif-
ferent parameters were atrial inflammation (S coeﬀ. = 0.254,
P = 0.002), ventricle compact layer inflammation (S coeﬀ. =
0.297, P = 0.001), ventricle trabecular inflammation (S coeﬀ.
= 0.166, P = 0.049), skeletal muscle inflammation (S coeﬀ. =
0.373, P = 0.001), ventricle epicarditis (S coeﬀ. = 0.20, P =
0.016), and skeletal muscle necrosis (S coeﬀ. = 0.414, P =
0.001) (Table 3). However, few non-significant relationships
were identified for LDH and anatomical parameters such
as ventricle compact layer necrosis (S coeﬀ. = 0.080, P =
0.341), ventricle trabecular necrosis (S coeﬀ. = 0.052, P =
0.534), atrial necrosis (S coeﬀ. = 0.034, P = 0.688), and
atrial epicarditis (S coeﬀ. = −0.049, P = 0.558). There
were significant positive correlations between LDH levels
and the total inflammation (S coeﬀ. = 0.266, P < 0.001)
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Figure 3: The box plots of all seven groups of Atlantic salmon on the basis of (a) total inflammation and (b) total necrosis in the heart and
skeletal muscle (N = 173). Group 1 (n = 28) and group 2 (n = 16) represented fish from an acute and late phase of a HSMI outbreak,
respectively, while group 3 (n = 31) represented values from fish from an early phase of HSMI, and group 4 (n = 30) included chronic CMS
fish. Group 5 (n = 28), group 6 (n = 20), and group 7 (n = 20) represented values from nondiseased (non-HSMI) fish. Higher scores of
inflammation and necrosis were found in diseased (groups 1, 2, 3, and 4) fish while low levels of scores in nondiseased (groups 5, 6, and 7)
fish were present. Bars with diﬀerent letters represented significant diﬀerences between groups (P < 0.05). (◦) denotes outliers.
Table 3: The Spearman correlation coeﬃcient for anatomically distinct regions of the HSMI and CMS infected fish to creatine kinase (CK)
and lactate dehydrogenase (LDH). P values given in parentheses.
Parameter
HSMI CMS
CK LDH CK LDH
Ventricle compact necrosis 0.249 (0.002) 0.080 (0.341) — —
Ventricle trabecular necrosis 0.283 (<0.001) 0.052 (0.534) 0.198 (0.291) 0.122 (0.516)
Atrium necrosis 0.252 (0.002) 0.034 (0.688) 0.327 (0.077) 0.242 (0.195)
Skeletal muscle necrosis 0.206 (0.035) 0.414 (0.001) 0.068 (0.719) −0.024 (0.899)
Ventricle compact inflammation 0.440 (<0.001) 0.297 (0.001) — —
Ventricle trabecular inflammation 0.526 (<0.001) 0.166 (0.049) 0.157 (0.405) −0.043 (0.822)
Atrial inflammation 0.451 (<0.001) 0.254 (0.002) 0.108 (0.580) 0.052 (0.790)
Ventricle epicarditis 0.333 (<0.001) 0.20 (0.016) 0.340 (0.065) 0.309 (0.096)
Atrium epicarditis 0.314 (<0.001) −0.049 (0.558) — —
Muscle inflammation 0.169 (0.084) 0.373 (0.001) — —
Total inflammation 0.552 (<0.001) 0.266 (<0.001) 0.089 (0.635) −0.075 (0.691)
Total necrosis 0.526 (<0.001) 0.247 (0.003) 0.355 (0.075) 0.240 (0.209)
and total necrosis (S coeﬀ. = 0.247, P < 0.003) scores
(Table 3). The correlations between CK enzyme levels and
diﬀerent anatomical parameters of all fish groups excluding
HSMI fish (groups 1, 2, and 3) identified non-significant
relationships (P = 0.05) (Table 3). The correlations made
between CK levels and diﬀerent anatomical regions were
atrial inflammation (S coeﬀ. = 0.108, P = 0.580), atrial
necrosis (S coeﬀ. = 0.327, P = 0.077), ventricle trabecular
inflammation (S coeﬀ. = 0.157, P = 0.405), ventricle
trabecular necrosis (S coeﬀ. = 0.198, P = 0.291), ventricle
epicarditis (S coeﬀ. = 0.340, P = 0.065), and skeletal muscle
necrosis (S coeﬀ. = 0.068, P = 0.719). The LDH levels
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Table 4: Blood serum enzymes in diﬀerent fish groups (Mean ± SE).
Creatine kinase (IU.L−1) Lactate dehydrogenase (IU.L−1)
Group 1 16479.25± 1844.49 697.43± 56.61
Group 2 10280± 5246.18 1838.25± 957.47
Group 3 8333.34± 1709.08 966± 71.94
Group 4 5207.93± 967.81 426.2± 60.68
Group 5 1581.71± 425.33 235.39± 27.43
Group 6 7098.35± 2916.95 1027.9± 334.04
Group 7 10297.15± 1531.11 423.3± 53.06
were also correlated in the same manner as above for CK
and included atrial inflammation (S coeﬀ. = 0.052, P =
0.790), atrial necrosis (S coeﬀ. = 0.242, P = 0.195), ventricle
trabecular inflammation (S coeﬀ. = −0.043, P = 0.822),
ventricle trabecular necrosis (S coeﬀ. = 0.122, P = 0.516),
ventricle epicarditis (S coeﬀ. = 0.309, P = 0.096), and
skeletal muscle necrosis (S coeﬀ. = −0.024, P = 0.899). The
combined CMS and nondiseased group’s correlations with
CK levels were also made in the same manner as described
above and identified correlations for total inflammation (S
coeﬀ. = 0.089, P = 0.635) and total necrosis (S coeﬀ. =
0.355, P = 0.075) scores (Table 3). There were non-signif-
icant negative and positive correlations between LDH levels
and total inflammation and total necrosis for CMS group,
respectively (Table 3).
4. Discussion
The CK and LDH values of all seven fish groups were com-
pared and diseased fish (HSMI) identified with significantly
higher enzymes levels as compared to nondiseased fish.
The significantly higher and lower mean enzymes levels in
diseased and nondiseased fish, respectively, were consistent
with the CK enzyme ranges already reported in farmed
Atlantic salmon aﬀected with a similar pancreas disease (PD)
[30, 31]. The highest mean LDH levels were identified at the
earlier phase of HSMI disease while highest CK levels were
present in acute phase of the disease. Previous in vivo studies
identified the increased CK and LDH activities in Atlantic
salmon and Nile tilapia (Oreochromis niloticus) treated with
tributyltin (TBT) and cadmium, respectively [35, 36].
Histopathology was used as a method of choice to
diagnose the diseases (HSMI and CMS). This study described
the histopathology in the heart and skeletal muscle by
using a semiquantitative scoring system that addressed the
pathological changes in both tissues (cardiac and somatic
muscle). The diseased fish showed the histopathological
changes in the heart and skeletal muscle similar to HSMI and
in hearts for CMS fish [5, 11, 13]. The histological changes
were identified in both atrium and ventricle (compact and
trabecular) of HSMI fish while mostly ventricular trabecular
layer was involved in CMS fish. The histopathological
changes were compared for all seven fish groups, and hearts
were identified with most tissue damage and suggested to be
the contributing source of enzymes (CK and LDH) which
released upon cellular damage and in line with Rodger et al.
[30] that suggested the significantly higher CK levels due to
myopathy in PD-aﬀected Atlantic salmon.
The mean CK levels and histopathology scores for acute
phase HSMI fish (group 1) were doubled than early or late
phase of HSMI fish (groups 2 and 3), and mean CK levels
(group 1) were up to four times greater than nondiseased fish
(groups 5 and 6). These higher CK levels and total inflamma-
tion scores were suggested to be the disease (HSMI) outcome
and supported the notion that fish included in group 1 were
in the acute phase of disease whereas groups 2 and 3 were not
in clinical phase of a HSMI outbreak. The acute phase of the
disease (HSMI) corresponded to higher mortality rates on
the farm and creatine kinase levels in blood sustained over 3-
4 days in humans where a cardiac injury has occurred [28].
The HSMI-infected fish showed significantly higher
histopathological scores as compared to the nondiseased fish.
The higher histopathological scores were consistent with the
higher CK levels in diseased fish as compared to nondiseased
fish, supported the higher enzymes levels likely due to
myopathy. The total inflammation scores were doubled as
compared to the total necrosis scores in all HSMI fish which
were considered as clinical sign of HSMI while necrosis being
suggested as a secondary eﬀect [13, 15]. The mean CK and
LDH levels and total necrosis scores for chronic CMS fish
were equal or lower to the nondiseased fish suggested no
correlation to CMS fish and supported the hypothesis that
increased enzymes levels identified in the HSMI fish were
related to myopathy [30, 31]. The fish cages that experienced
the CMS outbreak showed high inflammation scores as
compared to other cages on the same farm that were not
diagnosed with CMS, and both CMS and non-CMS fish had
higher values of enzymes indicating that CK and LDH were
not correlated to the chronic CMS fish histopathology scores.
The significantly positive correlations were identified
with biochemical enzymes (CK and LDH) and histopatho-
logical changes in HSMI-aﬀected Atlantic salmon [12, 24].
The histopathological scores for anatomically distinct areas
of heart and skeletal muscle were correlated significantly with
respective CK and LDH levels of the fish (P = 0.05). The
serum enzymes (CK and LDH) correlations have been used
previously to find significant relationships in great sturgeon
(Huso huso) and rainbow trout (Oncorhynchus mykiss) [24,
37, 38]. The correlations between histopathology (inflamma-
tion and necrosis) and enzymes (CK and LDH) values were
significant and positive, and suggested the HSMI disease
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eﬀects on blood biochemistry of Atlantic salmon and con-
sistent with mammalian studies where blood biochemistry
is changed in pathological conditions and used to predict
the disease [29, 36]. The correlation of CK levels to HSMI
histopathology appeared useful due to the release of CK after
tissue injury and potential contribution in limited piscine
blood biochemistry [28]. However, the CMS group showed
non-significant correlations between histology and enzymes
and suggested that blood biochemistry of Atlantic salmon
might not be aﬀected due to chronic CMS disease. Another
reason for no correlation of chronic CMS fish might include
the time of fish sampling which was conducted 6 months
after acute phase of disease while biochemical enzymes (CK
and LDH) release rapidly following tissue injury with peak
levels for 10–12 days in human [28]. It was also supported
by the fact that chronic CMS fish did not show signs (higher
mortality levels) and severe histopathological lesions charac-
teristic of acute phase of disease suggesting the late or chronic
phase of disease. However, further studies are required to
completely understand the CMS disease eﬀects on the blood
biochemistry. Histopathology is still a diagnostic method of
choice in clinical case of HSMI even though the recent iden-
tification of a reovirus associated with the disease allows the
possibility of identifying infected animals. However, asymp-
tomatic Atlantic salmon have been identified with piscine
reovirus and piscine myocarditis virus by RT-qPCR [17, 25].
However, it is a terminal procedure performed after the onset
of disease and there has been as observed increase mortality
level on farm, and mis-diagnosis may result with diseases
such as PD and CMS presenting similar pathological changes
to HSMI [12]. The blood biochemistry tests may prove useful
and have been proved useful in the detection and diagnosis of
metabolic disturbances in a number of diseases [39]. The use
of serum enzymes to diagnose the cardiac diseases in humans
is a common practice and a well-established method. The
CK and LDH levels are aﬀected in the cardiac diseases and
serve as disease indicators in humans [26]. Previous attempts
at measuring CK values were made in similar disease such
as pancreas disease (PD) but were not correlated directly
and extensively with histopathology [30, 31]. These studies
have been shown the significantly increased CK levels and
suggested the tissue damage as source of enzyme. HSMI fish
exhibited higher mean histopathology scores and enzymes
(CK and LDH) levels, and serum enzymes showed significant
positive correlations to histopathology which supported
the notion that CK and LDH levels were aﬀected due to
natural HSMI outbreak. The use of CK and LDH enzymes
haematological levels for pathological changes at least for
HSMI appeared promising and a potential contribution in
the limited piscine blood biochemistry by identifying the
enzyme ranges in the above-mentioned fish groups [22].
In conclusion, the present study measured the CK and
LDH levels in diseased and nondiseased Atlantic salmon
and correlated significantly to the histopathology of Atlantic
salmon aﬀected with natural HSMI outbreaks while being
non-significant to chronic CMS. The significantly higher CK
levels correlated positively and significantly to HSMI patho-
logical changes, suggesting that the potential use of serum
enzymes for screening HSMI is promising. The findings of
the present study should be considered as a contribution
to the more extensive research necessary to understand
biological activities (enzymes) and the pathological changes
of Atlantic salmon.
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